Funding Support and Author Disclosures Dr. Santos has received honoraria related to consulting, research, or speaker activities from Abbott, Amgen, Aché, AstraZeneca, Esperion, EMS, GETZ Pharma, Kowa, Libbs, Merck, MSD, Novo Nordisk, Novartis, PTC Therapeutics, Pfizer, and Sanofi. Dr. Shapiro has served on scientific advisory boards for Alexion, Amgen, Esperion, and Novartis. Dr. Ballantyne has received grant/research support (paid through his institution) from Abbott Diagnostic, Akcea, Amgen, Esperion, Ionis, Novartis, Regeneron, and Roche Diagnostic; and has served as a consultant for Abbott Diagnostics, Althera, Amarin, Amgen, Arrowhead, AstraZeneca, Corvidia, Denka Seiken, Esperion, Genentech, Gilead, Matinas BioPharma Inc., New Amsterdam, Novartis, Novo Nordisk, Pfizer, Regeneron, Roche Diagnostic, and Sanofi-Synthelabo.